Stocks
Amicus Therapeutics, Inc.FOLD
NASDAQHealthcareBiotechnology$14.37+0.00%
Focused on developing advanced therapies for rare and orphan diseases, this biopharmaceutical company has gained attention for its innovative treatments targeting lysosomal storage disorders. Investors closely monitor its pipeline progress and regulatory milestones, particularly for its enzyme replacement and gene therapies.
Market Cap: $4.5B52W Range: $5.51 – $14.39
Congressional Interest in Amicus Therapeutics, Inc. (FOLD)
1 member of Congress has disclosed 1 trade in Amicus Therapeutics, Inc. (FOLD), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading FOLD?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-04-10 | Daniel Goldman | sell | $1K – $15K |